Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor (NYSE: OMI) has announced significant financial developments and strategic initiatives. The company has achieved a total debt reduction of $647 million over two years, with $244 million reduced in 2024. The company is actively pursuing the sale of its Products & Healthcare Services (P&HS) segment and has authorized a $100 million share repurchase program over 24 months.
For 2025, OMI projects revenue between $10.85-11.15 billion, adjusted EBITDA of $560-590 million, and adjusted EPS of $1.60-1.85. The guidance indicates double-digit adjusted EBITDA and EPS growth with improving cash flow. The outlook excludes impacts from the announced Rotech acquisition, potential P&HS segment sale, and share repurchase activity.
Owens & Minor (NYSE: OMI) has launched ByramConnect, a digital health platform powered by the Welldoc App, exclusively for Byram Healthcare customers. The FDA-cleared class II software medical device is designed to help patients with type 1 or type 2 diabetes and associated chronic conditions.
The platform combines AI-driven digital health coaching, self-tracking, and clinical insights across six health dimensions. It integrates with various devices including blood glucose meters, CGMs, blood pressure monitors, and fitness trackers. Clinical studies have shown improvements in key metrics including reduced A1C, lower blood pressure, and reduced body weight.
Key features include personalized digital coaching, diet and nutrition support, GLP-1 medication management, health reporting with actionable insights, and mental wellbeing guidance. The service is available at no additional charge to Byram diabetes customers.
Owens & Minor (NYSE: OMI) has announced preliminary financial results for Q4 and full-year 2024, coinciding with financing activities for its planned Rotech Healthcare acquisition. The company expects to report Q4 2024 revenue of $2.67-$2.70 billion and full-year revenue of $10.67-$10.70 billion.
Key highlights include a non-cash goodwill impairment charge of approximately $310 million in the Apria division, resulting in a net loss of $(311)-(288) million for Q4 and $(378)-(355) million for the full year. The Patient Direct segment showed mid-single digit growth, and the company reduced total debt by over $240 million in 2024.
The company's Q4 Adjusted EBITDA is expected at $135-$140 million, with full-year Adjusted EBITDA of $520-$525 million. Full-year total debt stands at $1.854-$1.859 billion. The company plans to release complete financial results on February 28, 2025.
Owens & Minor (NYSE: OMI) has announced its participation in two upcoming investor conferences in December 2024. The company will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, Florida on December 4 at 8:45 a.m. ET, and at the Bank of America Home Care Conference virtually on December 9 at 12:00 p.m. ET. Both events will include individual investor meetings.
Owens & Minor is a Fortune 500 global healthcare solutions company that provides essential products and services from hospital to home care. With over 20,000 teammates worldwide, the company operates through affiliated brands including Apria, Byram, and HALYARD.
Owens & Minor (NYSE: OMI) reported Q3 2024 financial results with consolidated revenue of $2.7 billion, up 5% year-over-year. The company posted a GAAP net loss of $(13) million or $(0.17) per share, with adjusted earnings per share of $0.42. Patient Direct revenue grew 6% to $687 million, while Products & Healthcare Services revenue increased 5% to $2.0 billion. The company achieved $198 million in total debt reduction and reported adjusted EBITDA of $142 million, up 5% year-over-year. For 2024, guidance includes revenue of $10.6-10.8 billion, adjusted EBITDA of $540-550 million, and adjusted EPS of $1.45-1.55.
Owens & Minor (NYSE: OMI) has announced its plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day.
Participants can access the call via toll-free dial-in at 1-888-300-2035 or toll dial-in at 1-646-517-7437, using the conference ID access code 1058917. A simultaneous live webcast will be available on the Investor Relations page of the Owens & Minor website. A replay of the webcast can be accessed following the presentation.
Owens & Minor is a Fortune 500 global healthcare solutions company providing essential products and services that support care from hospital to home. With over 100 years of experience, the company and its affiliated brands serve patients, providers, and communities worldwide.
Owens & Minor (NYSE: OMI) has appointed Jonathan Leon as Executive Vice President and Chief Financial Officer, effective immediately. Leon, who has been with the company since 2017, will retain his corporate treasurer responsibilities while a search for his successor is underway. He brings over 25 years of experience in corporate finance, treasury, and strategy to the role.
Leon previously served as Interim CFO and Corporate Treasurer since June 2024. He will report directly to Edward Pesicka, President and CEO of Owens & Minor. Before joining the company, Leon spent 18 years at The Brink's Company in various finance roles. The appointment follows a comprehensive process, with the Board unanimously agreeing on Leon's suitability for the position.
Owens & Minor (OMI) has announced a new partnership with Google Cloud to enhance its QSight® clinical inventory management system. This collaboration aims to optimize complex inventory management for hospitals and health systems by leveraging Google Cloud's Vertex AI platform. The partnership will focus on improving QSight's ability to manage medical supplies, surgical implants, and human tissue products more efficiently.
Key benefits include:
- Enhanced real-time visibility and predictive capabilities
- Improved cost management and efficiency
- Reduced risk of expired product usage
- Decreased inventory loss
Owens & Minor (NYSE: OMI), a Fortune 500 global healthcare solutions company, has announced its participation in the 2024 Baird Global Healthcare Conference in New York City. Ed Pesicka, President and CEO, and Jon Leon, Corporate Treasurer and interim CFO, will engage in a fireside chat on Tuesday, September 10, 2024, at 1:25 p.m. EDT. The company will also host one-on-one meetings with investors during the conference.
Owens & Minor, celebrating over 100 years in business, provides essential products and services supporting healthcare from hospital to home. With affiliated brands Apria®, Byram®, and HALYARD*, the company employs more than 20,000 teammates worldwide. Their mission is to make each day better for patients, providers, and communities they serve, embodying their slogan 'Life Takes Care™'.
Owens & Minor (NYSE: OMI) reported Q2 2024 financial results with consolidated revenue of $2.7 billion, up 4% year-over-year. The company posted a net loss of $(32) million or $(0.42) per share, but doubled its adjusted earnings per share to $0.36. Adjusted EBITDA grew 12% to $127 million. Key highlights include:
- Patient Direct revenue up 4% to $660 million
- Products & Healthcare Services revenue up 4% to $2.0 billion
- Operating cash flow of $116 million, enabling $71 million debt reduction
- Announced agreement to acquire Rotech Healthcare Holdings
OMI reaffirmed its 2024 guidance, projecting revenue of $10.5-$10.9 billion and adjusted EBITDA of $550-$590 million. The company recorded a one-time tax charge of $17 million related to past transfer pricing methodology.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
What does Owens & Minor, Inc. do?
Where is Owens & Minor headquartered?
What are the main segments of Owens & Minor's business?
Who are Owens & Minor's customers?
How much revenue does Owens & Minor generate annually?
What regions do Owens & Minor serve?
What recent achievements has Owens & Minor accomplished?
What is the focus of the Products & Healthcare Services segment?
What does the Patient Direct segment do?
Where can I find more information about Owens & Minor?
